There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oak Street Health (OSH) and Quidel (QDEL) with bullish sentiments.
Oak Street Health (OSH)
Raymond James analyst John Ransom maintained a Buy rating on Oak Street Health yesterday. The company’s shares closed last Monday at $53.62.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 15.5% and a 64.6% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, AmerisourceBergen, and Encompass Health.
Currently, the analyst consensus on Oak Street Health is a Strong Buy with an average price target of $67.00, a 25.2% upside from current levels. In a report issued on January 28, Wolfe Research also initiated coverage with a Buy rating on the stock with a $62.00 price target.
See today’s analyst top recommended stocks >>
Quidel (QDEL)
In a report released today, Andrew Cooper from Raymond James initiated coverage with a Buy rating on Quidel. The company’s shares closed last Monday at $232.88.
According to TipRanks.com, Cooper is a 5-star analyst with an average return of 45.7% and a 89.3% success rate. Cooper covers the Healthcare sector, focusing on stocks such as Orasure Technologies, Idexx Laboratories, and Progenity.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Quidel with a $300.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
